1AD Application for quotation of securities - 1AD |
15/03/24 | | 15.38KB | Share |
|
1AD Corporate Presentation |
08/03/24 | PRICE SENSITIVE | 6.77MB | Share |
|
1AD Share Cafe webinar on Phase I results |
07/03/24 | | 147.32KB | Share |
|
1AD Positive AD-214 Phase I extension study results |
06/03/24 | PRICE SENSITIVE | 348.79KB | Share |
|
1AD Half Yearly Report and Accounts |
27/02/24 | PRICE SENSITIVE | 2.25MB | Share |
|
1AD Australia Biologics Festival Presentation |
20/02/24 | | 7.4MB | Share |
|
1AD Quarterly Appendix 4C and Activities Report |
31/01/24 | PRICE SENSITIVE | 535.77KB | Share |
|
1AD January 2024 partnering presentations and progress |
22/01/24 | PRICE SENSITIVE | 3.56MB | Share |
|
1AD Notification regarding unquoted securities - 1AD |
10/01/24 | | 26.93KB | Share |
|
1AD Change of Director's Interest Notice (TO) |
20/12/23 | | 241.35KB | Share |
|
1AD New malaria inhibiting i-body |
19/12/23 | PRICE SENSITIVE | 183.61KB | Share |
|
1AD Application for quotation of securities - 1AD |
19/12/23 | | 24.69KB | Share |
|
1AD Application for quotation of securities - 1AD |
19/12/23 | | 26.96KB | Share |
|
1AD Application for quotation of securities - 1AD |
19/12/23 | | 24.7KB | Share |
|
1AD Change of Director's Interest Notice x 4 (TO, PM, DF & RP) |
19/12/23 | | 419.64KB | Share |
|
1AD AdAlta launches new InvestorHub |
18/12/23 | | 175.72KB | Share |
|
1AD Results of Meeting |
14/12/23 | | 180.25KB | Share |
|
1AD Chair address to EGM |
14/12/23 | | 168.12KB | Share |
|
1AD Investor Webinar Presentation |
23/11/23 | | 146.6KB | Share |
|
1AD Results of Meeting |
22/11/23 | | 162.11KB | Share |
|
1AD Chair address and CEO presentation to AGM |
22/11/23 | PRICE SENSITIVE | 7.14MB | Share |
|
1AD AD-214 Phase I extension clinical study - interim results |
21/11/23 | PRICE SENSITIVE | 175.87KB | Share |
|
1AD Becoming a substantial holder |
20/11/23 | | 344.19KB | Share |
|
1AD Change in substantial holding |
16/11/23 | | 153.84KB | Share |
|
1AD Letter to Shareholders, Notice of EGM & Proxy Form |
15/11/23 | | 549.11KB | Share |
|
1AD Application for quotation of securities - 1AD |
14/11/23 | | 26.86KB | Share |
|
1AD Update - Proposed issue of securities - 1AD |
09/11/23 | | 27.4KB | Share |
|
1AD Update - Proposed issue of securities - 1AD |
09/11/23 | | 25.4KB | Share |
|
1AD Proposed issue of securities - 1AD |
09/11/23 | | 27.05KB | Share |
|
1AD Proposed issue of securities - 1AD |
09/11/23 | | 24.78KB | Share |
|
1AD Oversubscribed placement result |
07/11/23 | PRICE SENSITIVE | 324.5KB | Share |
|
1AD Proposed issue of securities - 1AD |
03/11/23 | | 27.42KB | Share |
|
1AD Proposed issue of securities - 1AD |
03/11/23 | | 25.59KB | Share |
|
1AD Prospectus |
03/11/23 | PRICE SENSITIVE | 620.56KB | Share |
|
1AD Placement to raise up to $1.23million |
03/11/23 | PRICE SENSITIVE | 343.28KB | Share |
|
1AD Trading Halt |
03/11/23 | PRICE SENSITIVE | 387.05KB | Share |
|
1AD Investor Presentation |
27/10/23 | PRICE SENSITIVE | 7.24MB | Share |
|
1AD Quarterly Appendix 4C and Activities Report |
27/10/23 | PRICE SENSITIVE | 417.17KB | Share |
|
1AD AD-214 well tolerated in Phase I extension study |
23/10/23 | PRICE SENSITIVE | 343.23KB | Share |
|
1AD Letter to Shareholders, Notice of AGM & Proxy Form |
20/10/23 | | 1.28MB | Share |
|
1AD AD-214 oral presentation at MPGPCR23 |
19/10/23 | | 358.96KB | Share |
|
1AD R&D tax refund received & R&D Loan repayment terms extended |
18/10/23 | PRICE SENSITIVE | 214.24KB | Share |
|
1AD Investor roadshow with IPF survivor Bill van Nierop |
13/10/23 | | 360.15KB | Share |
|
1AD Notification regarding unquoted securities - 1AD |
12/10/23 | | 25.01KB | Share |
|
1AD Notification of cessation of securities - 1AD |
12/10/23 | | 21.54KB | Share |
|
1AD Cleansing Notice under Section 708A |
27/09/23 | | 344.17KB | Share |
|
1AD Application for quotation of securities - 1AD |
27/09/23 | | 25.32KB | Share |
|
1AD Prof Foley invited presentation AD-214 |
26/09/23 | PRICE SENSITIVE | 11.02MB | Share |
|
1AD Dosing simulations support AD-214 IV product profile |
25/09/23 | PRICE SENSITIVE | 2.19MB | Share |
|
1AD Notification of Date of 2023 AGM |
22/09/23 | | 232.34KB | Share |
|
1AD AD-214 Phase I extension study fully enrolled |
20/09/23 | PRICE SENSITIVE | 215.38KB | Share |
|
1AD Appendix 4G and Corporate Governance Statement |
25/08/23 | | 589.46KB | Share |
|
1AD Annual Report to shareholders |
25/08/23 | | 1.29MB | Share |
|
1AD Preliminary Final Report |
25/08/23 | PRICE SENSITIVE | 416.83KB | Share |
|
1AD Investor webinar - recent AD-214 progress |
07/08/23 | | 336.87KB | Share |
|
1AD AD-214 returns to clinic |
04/08/23 | PRICE SENSITIVE | 387.83KB | Share |
|
1AD Change in substantial holding |
21/07/23 | | 142.13KB | Share |
|
1AD Change in substantial holding |
14/07/23 | | 152.92KB | Share |
|
1AD Notification of cessation of securities - 1AD |
14/07/23 | | 21.54KB | Share |
|
1AD Cleansing Notice under Section 708A |
13/07/23 | | 310.36KB | Share |
|
1AD Application for quotation of securities - 1AD |
13/07/23 | | 26.58KB | Share |
|
1AD Application for quotation of securities - 1AD |
13/07/23 | | 24.7KB | Share |
|
1AD Investor Presentation |
13/07/23 | PRICE SENSITIVE | 6.08MB | Share |
|
1AD $1.87 million raised in oversubscribed Shortfall facility |
13/07/23 | PRICE SENSITIVE | 757.53KB | Share |
|
1AD Quarterly Appendix 4C and Activities Report |
13/07/23 | PRICE SENSITIVE | 553.96KB | Share |
|
1AD New AD-214 data de-risks clinical studies |
07/07/23 | PRICE SENSITIVE | 576.07KB | Share |
|
1AD AD-214 clinical trial approval |
29/06/23 | PRICE SENSITIVE | 308.02KB | Share |
|
1AD Change in substantial holding |
31/05/23 | | 142.35KB | Share |
|
1AD Change in substantial holding |
31/05/23 | | 156.65KB | Share |
|
1AD Change of Director's Interest Notice x 2 (TO & DF) |
31/05/23 | | 305.02KB | Share |
|
1AD Top 20 Option Holders & Distribution Schedule |
29/05/23 | | 87.81KB | Share |
|
1AD Application for quotation of securities - 1AD |
29/05/23 | | 26.91KB | Share |
|
1AD Investor Summit live and recorded presentation |
29/05/23 | | 261.41KB | Share |
|
1AD Investor presentation |
25/05/23 | | 5.15MB | Share |
|
1AD Rights Offer results |
25/05/23 | PRICE SENSITIVE | 311.86KB | Share |
|
1AD Notice of change of exercise price of options |
22/05/23 | | 268.69KB | Share |
|
1AD Despatch of Rights Offer documentation |
08/05/23 | | 263.88KB | Share |
|
1AD Investor Presentation - Rights Offer Webinar |
03/05/23 | | 5.26MB | Share |
|
1AD Letter to Ineligible Foreign Shareholders |
28/04/23 | | 200.42KB | Share |
|
1AD Application for quotation of securities - 1AD |
28/04/23 | | 29.37KB | Share |
|
1AD Letter to Eligible Shareholders |
28/04/23 | | 339.27KB | Share |
|
1AD Letter to Optionholders |
28/04/23 | | 332.74KB | Share |
|
1AD Target Market Determination |
28/04/23 | | 188.19KB | Share |
|
1AD Prospectus |
28/04/23 | PRICE SENSITIVE | 695.07KB | Share |
|
1AD Proposed issue of securities - 1AD |
28/04/23 | | 47.23KB | Share |
|
1AD Rights Offer to fund early return to clinic and growth |
28/04/23 | PRICE SENSITIVE | 314.86KB | Share |
|
1AD Quarterly Appendix 4C and Activities Report |
28/04/23 | PRICE SENSITIVE | 380.21KB | Share |
|
1AD Notification of cessation of securities - 1AD |
14/04/23 | | 21.46KB | Share |
|
1AD Notification regarding unquoted securities - 1AD |
14/04/23 | | 25.06KB | Share |
|
1AD Final Director's Interest Notice |
24/03/23 | | 213.39KB | Share |
|
1AD Retirement of Non-Executive Director |
24/03/23 | | 266.87KB | Share |
|
1AD ShareCafe webinar presentation 3 Mar 2023 |
02/03/23 | | 4.34MB | Share |
|
1AD Half Yearly Report and Accounts |
27/02/23 | PRICE SENSITIVE | 712.41KB | Share |
|
1AD Spark Plus Singapore Investor Presentation |
24/02/23 | | 4.99MB | Share |
|
1AD Becoming a substantial holder |
20/02/23 | | 140.69KB | Share |
|
1AD Cleansing Notice under Section 708A |
06/02/23 | | 317.72KB | Share |
|
1AD Application for quotation of securities - 1AD |
06/02/23 | | 24.73KB | Share |
|
1AD Application for quotation of securities - 1AD |
06/02/23 | | 24.73KB | Share |
|
1AD Proposed issue of securities - 1AD |
02/02/23 | | 24.77KB | Share |
|
1AD Proposed issue of securities - 1AD |
02/02/23 | | 24.55KB | Share |